x
Disclaimer
This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. BrainsWay D treatment is FDA cleared for patients with MDD who failed to respond to one or more anti-depressants in the current episode.
BrainsWay is ushering in a new era of brain disorder treatment. Through ongoing investment in R&D and in research initiatives ranging from large-scale multicenter trials to personalized medicine studies, BrainsWay represents the next-generation of treatments for depression, OCD, and other brain disorders, achieving outcomes not thought possible with traditional medical solutions.
-
Non-Invasive treatment
-
Short sessions
-
Optimal stimulation treatment
-
Effective treatment for treatment resistant neuro - psychiatry patients
BrainsWay Helps a Range of Disorders
-
Obsessive Compulsive Disorder (OCD) Treatment
BrainsWay Introduces the First FDA Cleared (De-Novo) Non-invasive Medical Device for the Treatment of OCD.
-
Major Depressive Disorder (MDD) Treatment
Major Depressive Disorder is a neuropsychiatric disorder that is expressed in emotional, physiological and behavioral effects.
BrainsWay By The Numbers
-
500K+
TREATMENTS DELIVERED
-
17
COUNTRIES
-
90%
OF POPULATION IS COVERED BY REIMBURSEMENT
Knowledge Is Power
Regain your confidence and learn more about BrainsWay’s groundbreaking technology.
Read what patients share about their experience
Electricfield estimation in deep transcranial magneticstimulation
Background:
Literature studies [Bersani et al., 2013] showed theability to treat different neuropsychiatric disorders using H1 coil,one of the coils belongs
Modelling of the Electric Field Distribution in Deep Transcranial Magnetic Stimulation in the Adolescence, in the Adulthood, and in the Old Age
Background:
In the last few years, deep transcranial magnetic stimulation (dTMS) has been used for the treatment of depressive disorders,which affect
Deep TMS of the insula using the H-coil modulates dopamine release: a crossover [11C] PHNO-PET pilot trial in healthy humans
Background:
Modulating the function of the insular cortex could be a novel therapeutic strategy to treat addiction to a variety of
Safety and Characterization of a Novel Multi-Channel TMS Stimulator
Background:
Stimulator technology has not changed significantly since the early days of TMS. Stimulation of a single-element coil using the sole